Safe Orthopaedics SA (EPA:ALSAF)
France · Delayed Price · Currency is EUR 0.6150
+0.0150 (2.50%)
Jun 26, 2026, 12:09 PM CET
Safe Orthopaedics Revenue
In the year 2024, Safe Orthopaedics had annual revenue of 5.04M EUR, down -13.24%. Safe Orthopaedics had revenue of 2.44M in the half year ending December 31, 2024, a decrease of -0.57%.
Revenue
5.04M
Revenue Growth
-2.95%
P/S Ratio
0.01
Revenue / Employee
65.47K
Employees
77
Market Cap
56.10K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.04M | -769.00K | -13.24% |
| Dec 31, 2023 | 5.81M | -51.00K | -0.87% |
| Dec 31, 2022 | 5.86M | 1.31M | 28.70% |
| Dec 31, 2021 | 4.55M | 896.00K | 24.49% |
| Dec 31, 2020 | 3.66M | -1.04M | -22.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 47.35B |
| EssilorLuxottica Société anonyme | 28.49B |
| Ipsen | 3.93B |
| Sartorius Stedim Biotech | 2.98B |
| Spineway | 12.81M |
| IntegraGen | 5.02M |
| bonyf | 309.37K |
| Neovacs | 199.27K |